Efficacy, Safety and Tolerability Study of Meloxicam Injection in Subjects After Abdominal Surgery
Condition: Pain, Post-operative Interventions: Drug: Meloxicam Injection 30mg; Drug: Meloxicam Injection 60mg; Drug: Nacl 0.9% Sponsors: Beijing Tide Pharmaceutical Co., Ltd; The Third Xiangya Hospital of Central South University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2023 Category: Research Source Type: clinical trials
Pain Relief After PrimaryTKA
Condition: Pain, Postoperative Interventions: Drug: Zynrelef (Bupivacaine 60 MG / Meloxicam 1.8 MG) Per 2.3 ML Extended Release Solution; Drug: Bupivacaine HCl 0.5% Injectable Solution; Procedure: primary total knee replacement Sponsor: Rothman Institute Orthopaedics Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 2, 2023 Category: Research Source Type: clinical trials